ProPhase Labs to Present at the Q4 Investor Summit Conference
November 10 2021 - 8:30AM
ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and
genomics company, announces today that Chairman and CEO Ted Karkus
will present at the Q4 Investor Summit Conference, which is being
held virtually from November 16 – 17, 2021.
Mr. Karkus will deliver his corporate
presentation on November 16 at 2:00 PM ET.
Investors can register here:
https://investorsummitgroup.com/
Mr. Karkus will be available for one-on-one
meetings throughout the conference.
About ProPhase LabsProPhase
Labs (Nasdaq: PRPH) (“ProPhase”) is a diversified biotech and
genomics company that seeks to leverage its CLIA lab services to
provide whole genome sequencing and research direct to consumers
and build a genomics data base to be used for further research.
ProPhase Precision Medicine, Inc. focuses on
genomics testing technologies, a comprehensive method for analyzing
entire genomes, including the genes and chromosomes in DNA. The
data obtained from genomic testing can help to identify inherited
disorders and tendencies, help predict disease risk, help identify
expected drug response, and characterize genetic mutations,
including those that drive cancer progression.
ProPhase Diagnostics offers a broad array of
clinical diagnostic and testing services at its CLIA certified
laboratories. ProPhase Diagnostics serves patients who may have
SARS-CoV-2 (COVID-19) through both saliva and nasal swab methods.
Critical to COVID testing, results are provided in under 24 hours.
ProPhase Diagnostics also offers PCR (polymerase chain reaction)
testing for Influenzas A and B and RSV; as well as antigen and
antibody/immunity tests to broaden its COVID-19 testing beyond
RT-PCR testing.
ProPhase Global Healthcare, Inc. was formed to
seek to expand the Company’s SARS-CoV-2 (COVID-19) testing into
other countries and to pursue additional healthcare-related
initiatives.
ProPhase Labs has decades of experience
researching, developing, manufacturing, distributing, marketing,
and selling OTC consumer healthcare products and dietary
supplements, including dietary supplements under the TK
Supplements® brand.
ProPhase actively pursues strategic investments
and acquisition opportunities for other companies, technologies,
and products. For more information,
visit www.ProPhaseLabs.com.
Contact:
CORE IRJules
Abraham917-885-7378julesa@coreir.com
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Apr 2023 to Apr 2024